Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
GLSI · net income · updated Jun 9, 2026
Core profitability metrics
GLSI · net income · margin · TTM · CAGRNet income was −$19.4M for FY2025 (fiscal year ending 2025-12-31), down 22.6% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · GLSI net income history · GLSI profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Greenwich LifeSciences, Inc. (GLSI) reported net income of −$19.4M for FY2025 (fiscal year ending 2025-12-31), down 22.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Greenwich LifeSciences, Inc. has not yet achieved annual profitability based on available data (9 fiscal years). The company has reported net losses across all available periods.
Greenwich LifeSciences, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Greenwich LifeSciences, Inc. net worth" — the company's market capitalization is a separate figure from GLSI net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
GLSI net income · 4 questionsGreenwich LifeSciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $19.4M for FY2025.
▸ Source: FMP /income-statement · GAAP · Greenwich LifeSciences, Inc. · Greenwich LifeSciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026